OrthoPediatrics Corp. (NASDAQ:KIDS) Short Interest Up 10.9% in December

OrthoPediatrics Corp. (NASDAQ:KIDS) was the recipient of a significant growth in short interest in December. As of December 31st, there was short interest totalling 912,100 shares, a growth of 10.9% from the December 15th total of 822,400 shares. Based on an average daily volume of 211,000 shares, the short-interest ratio is currently 4.3 days. Approximately 5.6% of the shares of the company are short sold.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Quarry LP purchased a new stake in shares of OrthoPediatrics in the third quarter worth $25,000. International Assets Investment Management LLC raised its holdings in shares of OrthoPediatrics by 2,610.8% in the 3rd quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock valued at $27,000 after acquiring an additional 966 shares in the last quarter. Quest Partners LLC purchased a new stake in shares of OrthoPediatrics in the 2nd quarter valued at about $34,000. BNP Paribas Financial Markets grew its holdings in shares of OrthoPediatrics by 125.1% during the third quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock worth $94,000 after purchasing an additional 1,929 shares in the last quarter. Finally, Quantbot Technologies LP increased its position in shares of OrthoPediatrics by 42.2% in the third quarter. Quantbot Technologies LP now owns 5,773 shares of the company’s stock worth $157,000 after purchasing an additional 1,712 shares during the last quarter. 69.05% of the stock is owned by institutional investors.

OrthoPediatrics Price Performance

Shares of KIDS stock traded up $0.63 during trading hours on Friday, reaching $27.16. The stock had a trading volume of 481,435 shares, compared to its average volume of 238,061. The stock’s fifty day simple moving average is $23.98 and its 200 day simple moving average is $27.34. The company has a current ratio of 7.17, a quick ratio of 3.68 and a debt-to-equity ratio of 0.19. The firm has a market capitalization of $657.82 million, a PE ratio of -22.08 and a beta of 1.14. OrthoPediatrics has a 12 month low of $21.02 and a 12 month high of $35.99.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on KIDS. Needham & Company LLC reissued a “buy” rating and set a $42.00 target price on shares of OrthoPediatrics in a report on Tuesday, January 14th. Truist Financial reduced their price target on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a research report on Wednesday, December 18th.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.